Mutations in the KRAS2 Oncogene During Progressive Stages of Human Colon Carcinoma

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1989 Apr 1

PMID 2648401

Citations 56

Authors

G C Burmer

L A Loeb

Affiliations

Soon will be listed here.

Abstract

A series of colon carcinomas, adenomas, and adjacent tissues were analyzed for ploidy alterations and mutations in KRAS2. To increase the sensitivity for identifying mutations, we used histological enrichment, cell sorting, and DNA amplification by the polymerase-catalyzed chain reaction followed by direct DNA sequence analysis. Of the 40 carcinomas analyzed, 27 contained aneuploid cells and 26 contained mutations at the first position of codon 12 of KRAS2. Of the 12 adenomas studied, 4 contained aneuploid cells and 9 contained the same mutation at codon 12. In both adenomas and carcinomas, mutations were identified in both diploid and aneuploid cells. In some cases, regions of histologically benign mucosa adjacent to the carcinoma contained mutations. These combined results suggest that mutations in KRAS2 occur early in the development of human colon carcinoma, before change in ploidy, and that these mutations exist in diploid cells from which an aneuploid subpopulation arises. Furthermore, mutations may exist in histologically normal mucosa in regions adjacent to carcinoma, suggesting that a field of genetically abnormal mucosa may surround these tumors.

Citing Articles

A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer.

Higami S, Mukai M, Yokoyama D, Uda S, Abe R, Mamuro N J Gastrointest Oncol. 2023; 14(2):663-675.

PMID: 37201062 PMC: 10186548. DOI: 10.21037/jgo-22-899.

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells.

Subbarayan K, Massa C, Leisz S, Steven A, Bethmann D, Biehl K Oncoimmunology. 2022; 11(1):2069214.

PMID: 35529675 PMC: 9067524. DOI: 10.1080/2162402X.2022.2069214.

Effects of molecular markers on the treatment decision and prognosis of colorectal cancer: a narrative review.

Cao Y, Wang X J Gastrointest Oncol. 2021; 12(3):1191-1196.

PMID: 34295567 PMC: 8261319. DOI: 10.21037/jgo-21-230.

The landscape and driver potential of site-specific hotspots across cancer genomes.

Juul R, Nielsen M, Juul M, Feuerbach L, Pedersen J NPJ Genom Med. 2021; 6(1):33.

PMID: 33986299 PMC: 8119706. DOI: 10.1038/s41525-021-00197-6.

Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients.

Prosenc Zmrzljak U, Kosir R, Krivokapic Z, Radojkovic D, Nikolic A Genes (Basel). 2021; 12(2).

PMID: 33669856 PMC: 7923234. DOI: 10.3390/genes12020289.

References

Monnat Jr R, Maxwell C, Loeb L . Nucleotide sequence preservation of human leukemic mitochondrial DNA. Cancer Res. 1985; 45(4):1809-14. View

Schmid K, Thomm M, Laminet A, Laue F, Kessler C, Stetter K . Three new restriction endonucleases MaeI, MaeII and MaeIII from Methanococcus aeolicus. Nucleic Acids Res. 1984; 12(6):2619-28. PMC: 318694. DOI: 10.1093/nar/12.6.2619. View

Goelz S, Hamilton S, Vogelstein B . Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun. 1985; 130(1):118-26. DOI: 10.1016/0006-291x(85)90390-0. View

Armitage N, Robins R, Evans D, Turner D, Baldwin R, Hardcastle J . The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg. 1985; 72(10):828-30. DOI: 10.1002/bjs.1800721018. View

Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich H . Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985; 230(4732):1350-4. DOI: 10.1126/science.2999980. View

Banner B, ROSEMAN D, Coon J . Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma?. Ann Surg. 1985; 202(6):740-4. PMC: 1251009. DOI: 10.1097/00000658-198512000-00014. View

Nowell P . Mechanisms of tumor progression. Cancer Res. 1986; 46(5):2203-7. View

Finan P, Quirke P, Dixon M, Dyson J, Giles G, Bird C . Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer?. Br J Cancer. 1986; 54(2):327-30. PMC: 2001527. DOI: 10.1038/bjc.1986.180. View

Terpstra O, van Blankenstein M, Dees J, Eilers G . Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology. 1987; 92(3):704-8. DOI: 10.1016/0016-5085(87)90021-7. View

10.

Bos J, Verlaan-de Vries M, Van Der Eb A, Janssen J, Delwel R, Lowenberg B . Mutations in N-ras predominate in acute myeloid leukemia. Blood. 1987; 69(4):1237-41. View

11.

Lipkin M . Biomarkers of increased susceptibility to gastrointestinal cancer. Their development and application to studies of cancer prevention. Gastroenterology. 1987; 92(4):1083-6. DOI: 10.1016/0016-5085(87)90987-5. View

12.

Stowers S, Glover P, Reynolds S, BOONE L, Maronpot R, Anderson M . Activation of the K-ras protooncogene in lung tumors from rats and mice chronically exposed to tetranitromethane. Cancer Res. 1987; 47(12):3212-9. View

13.

Bos J, Fearon E, Hamilton S, Verlaan-de Vries M, VAN Boom J, Van Der Eb A . Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987; 327(6120):293-7. DOI: 10.1038/327293a0. View

14.

Forrester K, Almoguera C, Han K, Grizzle W, Perucho M . Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature. 1987; 327(6120):298-303. DOI: 10.1038/327298a0. View

15.

Barbacid M . ras genes. Annu Rev Biochem. 1987; 56:779-827. DOI: 10.1146/annurev.bi.56.070187.004023. View

16.

Fearon E, Hamilton S, Vogelstein B . Clonal analysis of human colorectal tumors. Science. 1987; 238(4824):193-7. DOI: 10.1126/science.2889267. View

17.

Shibata D, Arnheim N, Martin W . Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med. 1988; 167(1):225-30. PMC: 2188813. DOI: 10.1084/jem.167.1.225. View

18.

Mullis K, Faloona F . Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987; 155:335-50. DOI: 10.1016/0076-6879(87)55023-6. View

19.

Farr C, Saiki R, Erlich H, McCormick F, Marshall C . Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci U S A. 1988; 85(5):1629-33. PMC: 279827. DOI: 10.1073/pnas.85.5.1629. View

20.

Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M . Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988; 53(4):549-54. DOI: 10.1016/0092-8674(88)90571-5. View